Doris O. Matsui

Digital Opportunity Foundation Act of 2026

The legislation would create a new Foundation for Digital Opportunity to help expand internet access and digital skills training for underserved communities across the country. This would affect low-income families, rural residents, and other groups who currently lack reliable broadband or the training needed to use digital tools effectively. The foundation would work to bridge the digital divide by funding programs that improve connectivity and provide education in technology skills.

Ensuring Excellence in Mental Health Act

The proposal would expand how Medicare and Medicaid pay for mental health and substance abuse services at community behavioral health clinics, potentially making these services more accessible and affordable for patients who need them. The changes would affect both the clinics that provide these services and the millions of Americans who rely on Medicare and Medicaid for their healthcare coverage.

Kari's Law Reporting Act

Kari's Law Reporting Act This bill requires the Federal Communications Commission (FCC) to publish a report on the enforcement of Kari’s Law, which requires multiline telephone systems to be preconfigured to allow users to dial 9-1-1 directly from any phone without dialing any additional code or prefix. The report must include (1) a summary of the extent to which multiline telephone system manufacturers and vendors have complied with the law, and any obstacles to their compliance; and (2) related recommendations for improvements to FCC policy or further legislation, if necessary.

Expressing support for honoring Earth Day, and for other purposes.

This resolution expresses congressional support for celebrating Earth Day and promoting environmental protection efforts. The measure has been referred to committees that handle energy, commerce, and foreign affairs issues to determine what specific environmental policies or international agreements it might address.

Emergency Reporting Act

Emergency Reporting Act This bill requires the Federal Communications Commission (FCC) to investigate and report on emergency communications outages (e.g., 9-1-1 outages). Specifically, the FCC must publish a general report on (1) the volume and nature of 9-1-1 outages that are not required to be reported under current outage notification rules, (2) the value and practicality of including visual information in outage notifications from communications providers, and (3) recommended changes to FCC rules to address these issues. Separately, the FCC must hold annual public hearings on events for which the Disaster Information Reporting System (DIRS) was activated for at least a week. (DIRS is a reporting system that is activated during severe weather and other events impacting communications service. It enables communications providers to report outages and other degradations to service.) After each such hearing, the FCC must issue a report that includes information about the number, duration, and nature of all associated outages, along with recommendations for improving the resiliency of affected communications services or networks. Such reports must generally be made public on the FCC website.

Drug Origin Transparency Act of 2026

The bill would require drug manufacturers to provide more detailed information about how much medication they're producing and distributing, giving the government better visibility into drug supply chains and potential shortages. This would help federal health agencies track whether there are enough medicines available and identify problems before they become widespread supply issues. The changes would primarily affect pharmaceutical companies and the FDA, which oversees drug safety and availability.

Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026.

This bill would make prescription medicines more affordable for seniors by allowing Medicare to negotiate drug prices directly with pharmaceutical companies and potentially allowing Americans to buy cheaper medications from other countries. The legislation aims to reduce what older adults pay out-of-pocket for prescriptions while potentially lowering overall healthcare costs for the Medicare program. Seniors, pharmaceutical companies, and Medicare would all be affected by these changes to how drug prices are set.

Reversionary Interest Conveyance Act

Reversionary Interest Conveyance Act This bill directs the Bureau of Land Management (BLM) to offer to sell the reversionary interest of the United States in approximately 8.43 acres of land in Sacramento, California, as generally depicted on a specified map dated November 7, 2022. Within two years of receiving a request from the owner of the land, the BLM must offer the reversionary interest and convey the reversionary interest to the buyer upon payment. The payment must be in an amount that is at least the fair market value of the reversionary interest. The buyer must also pay all costs related to the applicable conveyance of the reversionary interest, including all surveys, appraisals, and other administrative costs. The bill subjects the conveyance to valid existing rights. The proceeds from the sale must be deposited into Federal Land Disposal Account.

Whale CHARTS Act of 2026

The bill would establish new protections and monitoring systems for whale populations, likely requiring shipping companies and other industries to take steps to avoid harming whales in U.S. waters. It addresses concerns about whale deaths from ship strikes, fishing nets, and other human activities by creating tracking programs and safety requirements. The proposal affects shipping industries, fishing operations, and environmental organizations working to preserve marine mammals.

Senior Savings Protection Act

The bill aims to protect older Americans' savings and financial security, likely by establishing new rules or safeguards related to retirement accounts, Social Security benefits, or protections against financial fraud targeting seniors. The specific provisions would affect elderly citizens and potentially financial institutions or advisors who manage senior accounts. The bill is currently being reviewed by two congressional committees to determine which parts fall under their respective areas of responsibility.

340B PATIENTS Act of 2025

This bill would modify the 340B drug pricing program, which allows hospitals and other healthcare providers to purchase certain medications at discounted prices and pass those savings to uninsured and low-income patients. The changes would likely affect how hospitals use these discounts and could impact patients' access to affordable medications, as well as pharmaceutical companies' participation in the program. The specific reforms aim to address concerns about how the program currently operates and ensure the discounts reach the patients they were intended to help.

Climate Change Health Protection and Promotion Act of 2025

This bill would direct the federal government to study and address how climate change affects public health, requiring agencies to develop plans for protecting Americans from heat waves, air pollution, disease-carrying insects, and other climate-related health threats. It would likely fund research, establish warning systems, and help communities prepare for health emergencies caused by changing weather patterns, affecting everyone from vulnerable populations like elderly people and outdoor workers to the general public.

MAPS Act

Mapping America’s Pharmaceutical Supply Act or the MAPS Act This bill requires the Food and Drug Administration (FDA) to continually update its essential medicines list and identify risks and vulnerabilities in the associated supply chains. In 2020, in response to an executive order, the FDA published a list of essential medicines deemed medically necessary to have available at all times. The bill requires the FDA to update and maintain this list to include drugs and ingredients (1) related to responding to public health threats and emergency incidents, (2) that are of greatest priority for providing health care and are at high risk of shortage, and (3) the shortage of which would adversely affect patients with chronic conditions. The FDA must review the list at least every two years and update it as appropriate. Also, the bill requires the FDA to conduct a risk assessment of the supply chains for drugs and ingredients on the list and annually report its findings to Congress. The assessment must include information about key manufacturing materials, drugs with primarily foreign or single suppliers, manufacturing capacity, relevant public health and national security risks, and risk mitigation strategies. Additionally, the Department of Health and Human Services (HHS) must map and monitor relevant supply chains to identify vulnerabilities and provide an annual status report to Congress. HHS must facilitate the secure exchange of information among agencies regarding locations and quantities of production and relevant regulatory actions.

TREES Act of 2025

The proposal would establish or expand programs to promote tree planting and forest management as a way to reduce carbon emissions and address climate change. It would likely affect landowners, environmental organizations, and energy companies by creating incentives or requirements related to forest conservation and carbon sequestration. The bill aims to use natural forest growth as a tool to help meet energy and environmental goals.

Expressing support for honoring Earth Day, and for other purposes.

This resolution expresses congressional support for Earth Day and environmental protection efforts. The measure has been referred to committees for review but does not create new laws or require specific government actions—it serves primarily as a statement of the House's commitment to environmental causes.

Diesel Emissions Reduction Act of 2025

Diesel Emissions Reduction Act of 2025 This bill reauthorizes through FY2029 a diesel emissions reduction program under which the Environmental Protection Agency provides grants, rebates, or loans for replacing diesel engines or retrofitting the engines with pollution control technologies.